← All Sunshine Biopharma INC filings

Sunshine Biopharma INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
SBFM
Sunshine Biopharma INC
Form 4: Sunshine Biopharma Director Receives Stock Grant
David Natan, a Director of Sunshine Biopharma Inc., received 58,300 shares of common stock on August 7, 2026.
NASDAQ
SBFM
Sunshine Biopharma INC
Form 4: Director Receives Stock Award from Sunshine Biopharma
David Natan, a Director at Sunshine Biopharma Inc., received a stock award of 100,000 shares.
NASDAQ
SBFM
Sunshine Biopharma INC
Form 4: Sunshine Biopharma CEO Acquires and Disposes of Series B Preferred Stock
Steve N. Slilaty, CEO of Sunshine Biopharma, reports acquiring and disposing of Series B Preferred Stock on March 4, 2024.